Please provide your email address to receive an email when new articles are posted on . The rate of non-CRC malignancies at 1 year was 0.8% in the false-positive group and 0.9% in the true-negative ...

BRAF-positive non-small cell lung cancer (NSCLC) treatments can use the BRAF biomarker to provide effective, targeted treatment for this subset of lung cancer. BRAF-positive NSCLC is an uncommon or ...

Most types of breast cancer produce similar symptoms and are discovered the same way—finding a strange new lump during a self-exam, or a healthcare provider spotting something suspicious during a ...

When you have breast cancer, one of the most important things to know is whether the cancer is at an early stage or if it has spread. Stage, type, size, and location of your tumor all can play a role ...